Stocktoria
NewAmsterdam Pharma Co N.V. NAMS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-11-23
NewAmsterdam Pharma Co N.V. statistics & valuation
Market cap$3.9B
P / B5.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating margin | -1002.9% | -386.9% | -1298.6% | -3.5% |
| Net margin | -905.7% | -530.3% | -1255.8% | -22.0% |
| Return on assets | -26.5% | -27.9% | -51.0% | -4.7% |
| Return on equity | -29.8% | -31.9% | -61.4% | -5.3% |
| Current ratio | 7.88 | 8.08 | 6.95 | 13.26 |
| Revenue growth | -50.6% | 223.4% | -86.3% | — |
Source: SEC EDGAR filings · CIK 0001936258 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.